Ascendis Pharma (Brazil) Investor Sentiment

A1SN34 Stock  BRL 53.35  1.65  3.00%   
About 62% of Ascendis Pharma's investor base is looking to short. The analysis of current outlook of investing in Ascendis Pharma AS suggests that many traders are alarmed regarding Ascendis Pharma's prospects. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
  
2 days ago at news.google.com         
Frazier Life Sciences Management L.P. Invests 19.91 Million in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
3 days ago at news.google.com         
Wellington Management Group LLP Lowers Holdings in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
six days ago at news.google.com         
RA Capital Management L.P. Sells 7,972 Shares of Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Peering Into Ascendis Pharmas Recent Short Interest - Benzinga
Google News at Macroaxis
over two weeks ago at news.google.com         
Westfield Capital Management Co. LP Has 766.52 Million Position in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Can BioMarin Stock Live Up to Wall Streets High Expectations - Benzinga
Google News at Macroaxis
over two weeks ago at news.google.com         
Ascendis Pharma Q3 2024 Earnings Preview - MSN
Google News at Macroaxis
over three weeks ago at news.google.com         
Ascendis Pharma Third Quarter 2024 Earnings Misses Expectations - Simply Wall St
Google News at Macroaxis
over three weeks ago at news.google.com         
Ascendis Pharma Reports Third Quarter 2024 Financial Results - GlobeNewswire
Google News at Macroaxis
over a month ago at news.google.com         
Ascendis Pharma to Report Q3 2024 Earnings, Host Investor Call on November 14 ASND Stock News - Stoc...
Google News at Macroaxis
over two months ago at news.google.com         
Heres How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years - Benzinga
Google News at Macroaxis
over two months ago at news.google.com         
Ensign Peak Advisors Inc Reduces Holdings in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Ascendis Pharma Moves 17.1 percent Higher Will This Strength Last - MSN
Google News at Macroaxis
over two months ago at news.google.com         
Ascendis Pharma Details Share Capital Strategy - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Ascendis Pharma AS Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.

Ascendis Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing